BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17292867)

  • 1. Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.
    Yoneyama Y; Ueda Y; Akutsu Y; Matsunaga A; Shimada H; Kato T; Kubota-Akizawa M; Okano S; Shibata S; Sueishi K; Hasegawa M; Ochiai T; Yonemitsu Y
    Biochem Biophys Res Commun; 2007 Mar; 355(1):129-35. PubMed ID: 17292867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
    Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
    J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sendai virus for cancer immunotherapy.
    Ueda Y; Hasegawa M; Yonemitsu Y
    Methods Mol Biol; 2009; 515():299-308. PubMed ID: 19378123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene.
    Shibata S; Okano S; Yonemitsu Y; Onimaru M; Sata S; Nagata-Takeshita H; Inoue M; Zhu T; Hasegawa M; Moroi Y; Furue M; Sueishi K
    J Immunol; 2006 Sep; 177(6):3564-76. PubMed ID: 16951315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene.
    Tatsuta K; Tanaka S; Tajiri T; Shibata S; Komaru A; Ueda Y; Inoue M; Hasegawa M; Suita S; Sueishi K; Taguchi T; Yonemitsu Y
    Gene Ther; 2009 Feb; 16(2):240-51. PubMed ID: 18987675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
    Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
    J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties.
    Inoue M; Tokusumi Y; Ban H; Shirakura M; Kanaya T; Yoshizaki M; Hironaka T; Nagai Y; Iida A; Hasegawa M
    J Gene Med; 2004 Oct; 6(10):1069-81. PubMed ID: 15386740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
    Jeong HS; Lee H; Ko Y; Son YI
    Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.
    Kato T; Ueda Y; Kinoh H; Yoneyama Y; Matsunaga A; Komaru A; Harada Y; Suzuki H; Komiya A; Shibata S; Hasegawa M; Hayashi H; Ichikawa T; Yonemitsu Y
    Neoplasia; 2010 Nov; 12(11):906-14. PubMed ID: 21076616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
    Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
    Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
    Yonemitsu Y; Ueda Y; Kinoh H; Hasegawa M
    Front Biosci; 2008 May; 13():4953-9. PubMed ID: 18508560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells.
    O-Sullivan I; Ng LK; Martinez DM; Kim TS; Chopra A; Cohen EP
    Cancer Gene Ther; 2005 Oct; 12(10):825-34. PubMed ID: 15891775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids.
    Lee WT; Tamai H; Cohen P; Teker AM; Shu S
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):608-13. PubMed ID: 18559727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.
    Akutsu Y; Matsubara H; Urashima T; Komatsu A; Sakata H; Nishimori T; Yoneyama Y; Hoshino I; Murakami K; Usui A; Kano M; Ochiai T
    Int J Oncol; 2007 Sep; 31(3):509-15. PubMed ID: 17671676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
    Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
    J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.
    Murakami Y; Ikeda Y; Yonemitsu Y; Tanaka S; Kondo H; Okano S; Kohno R; Miyazaki M; Inoue M; Hasegawa M; Ishibashi T; Sueishi K
    J Gene Med; 2008 Feb; 10(2):165-76. PubMed ID: 18074401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.
    Matsushita K; Shimada H; Ueda Y; Inoue M; Hasegawa M; Tomonaga T; Matsubara H; Nomura F
    World J Gastroenterol; 2014 Apr; 20(15):4316-28. PubMed ID: 24764668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sendai virus for gene therapy and vaccination.
    Griesenbach U; Inoue M; Hasegawa M; Alton EW
    Curr Opin Mol Ther; 2005 Aug; 7(4):346-52. PubMed ID: 16121700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.